Observation of a Bone Invasion Model of Aspergillus fumigatus In Vitro and Analysis of the Antifungal Susceptibility

被引:0
|
作者
Shao, Yan [1 ]
Shen, Min [2 ]
Peng, Dan [2 ]
Cheng, Wenxu [2 ]
Mao, Chenggang [2 ]
Zhang, Heng [3 ]
Sun, Yi [3 ]
机构
[1] Yangtze Univ, Dept Orthoped, Jingzhou Hosp, Jingzhou, Hubei, Peoples R China
[2] Yangtze Univ, Jingzhou Hosp, Dept Otolaryngol Head & Neck Surg, Jingzhou, Hubei, Peoples R China
[3] Yangtze Univ, Jingzhou Hosp, Dept Neurosurg, Jingzhou 434020, Hubei, Peoples R China
关键词
Aspergillus fumigatus; Osteolytic; Invasive; Fungal infection; Antifungal drug; FUNGAL SINUSITIS; DIAGNOSIS;
D O I
10.1007/s11046-023-00817-y
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background Recently, the prevalence of invasive fungal infections has been on the rise, and one of the prevalent symptoms frequently observed is bone deterioration and bone loss.Materials and Methods Using an in vitro model we studied how Aspergillus fumigatus invades the bone. Pathological analysis was then employed to observe the structure and distinctive features of the invading fungal elements within the bone invasion model. Meanwhile, the antifungal effects of itraconazole, voriconazole, posaconazole, and amphotericin B were evaluated.Results The pathological findings showed that in the experimental group, fungal spores and hyphae invaded the bone tissue or were observed growing in the vicinity of the bone edge tissues, as indicated by both HE and PAS staining. In contrast, no fungal elements were observed in the control group, indicating that the in vitro bone invasion model of A. fumigatus was successfully constructed. Furthermore, the findings from the antifungal sensitivity test demonstrated that the lowest effective concentrations of antifungal drugs against the bone invasion model were as follows: 4 mu g/ml for itraconazole, 0.5 mu g/ml for voriconazole, 2 mu g/ml for posaconazole, and 2 mu g/ml for amphotericin B.Discussion The successful construction of the bone invasion model of A. fumigatus has provided a solid basis for future investigations into the mechanisms underlying A. fumigatus bone invasion and the study of its virulence factors. Utilizing bone models is of utmost importance in advancing the development of novel antifungal treatment approaches, as well as in effectively preventing and treating fungal bone invasion and osteolytic diseases.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Re-examination of clinical isolates collected as Aspergillus fumigatus - antifungal susceptibility and the frequency of the related species
    Watanabe, A.
    Kikuchi, K.
    Ito, J.
    Taguchi, H.
    Tamiya, H.
    Yaguchi, T.
    Kamei, K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S120 - S120
  • [42] Time of incubation for antifungal susceptibility testing of Aspergillus fumigatus:: Can MIC values be obtained at 24 hours?
    Rodriguez-Tudela, Juan Luis
    Alcazar-Fuoli, Laura
    Alastruey-Izquierdo, Ana
    Monzon, Araceli
    Mellado, Emilia
    Cuenca-Estrella, Manuel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (12) : 4502 - 4504
  • [43] In-vitro and in-vivo susceptibility of Aspergillus fumigatus to a novel conjugated styryl ketone
    Manavathu, EK
    Dimmock, JR
    Vashishtha, SC
    Cutright, J
    Chandrasekar, PH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (05) : 585 - 590
  • [44] Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus
    Mowat, Eilidh
    Butcher, John
    Lang, Sue
    Williams, Craig
    Ramage, Gordon
    JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (09) : 1205 - 1212
  • [45] The impact of NFAT inhibition in neutrophil antifungal defense in a murine Aspergillus fumigatus pneumonia model
    Teschner, D.
    Michel, C.
    Pruefer, S.
    Theobald, M.
    Schild, H.
    Radsak, M.
    Oncology Research and Treatment, 2015, 38 : 221 - 221
  • [46] Comment on: Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model
    Denning, David W.
    Ghnan, Nesrin
    Kwizera, Richard
    Osmanov, Ali
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (02) : 633 - 633
  • [47] In vitro antifungal susceptibility of clinical species belonging to Aspergillus genus and Rhizopus oryzae
    Kachuei, R.
    Khodavaisy, S.
    Rezaie, S.
    Sharifynia, S.
    JOURNAL DE MYCOLOGIE MEDICALE, 2016, 26 (01): : 17 - 21
  • [48] Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui, E
    Persat, F
    Monier, MF
    Borel, E
    Piens, MA
    Picot, S
    CANADIAN JOURNAL OF MICROBIOLOGY, 1999, 45 (10) : 871 - 874
  • [49] In vitro susceptibility of Aspergillus and Fusarium associated with equine keratitis to new antifungal drugs
    Roberts, Darby
    Cotter, Henry Van T.
    Cubeta, Marc
    Gilger, Brian C.
    VETERINARY OPHTHALMOLOGY, 2020, 23 (05) : 918 - 922
  • [50] In Vitro Antifungal Susceptibility of Clinically Relevant Species Belonging to Aspergillus Section Flavi
    Goncalves, Sarah S.
    Stchigel, Alberto M.
    Cano, Josep
    Guarro, Josep
    Colombo, Arnaldo L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1944 - 1947